Ongoing research involves the evaluation
of immune checkpoint inhibition in collaboration with the Ludwig / CRI CVC trials network and the pharmaceutical industry.
«We are pleased to have obtained the same results in two different laboratories and we look forward to translating these preclinical findings into combination approaches with entinostat to enhance the clinical activity
of immune checkpoint inhibition.»
Not exact matches
In this review we discuss how selected cancer - cell autonomous cues may influence the outcome
of cancer immunotherapy, particularly
immune checkpoint inhibition.
«The ability to predict progression to stage IV disease is extremely important in light
of recent findings that
immune checkpoint inhibition improves OS in stage III melanoma,» the researchers wrote.
The laboratory
of Linda Bradley, Ph.D., professor at SBP, recently published a paper identifying PSGL - 1, a protein that limits T cell responses to viruses, as a new target for
checkpoint inhibition, an approach akin to taking the «brakes» off the
immune system.